BAT's Bangladesh Arm Posts 67% Profit Slump as Capital Group Trims Stake and Goldman Turns Bullish
Published on 11/09/2026 at 05:52 | Editorial boerse-global.de
British American Tobacco's Bangladeshi subsidiary has reported a sharp deterioration in third-quarter earnings, with net profit after tax tumbling 67.28% year on year, according to media reports dated 29 October. For the July-to-September period, British American Tobacco Bangladesh booked Tk99.84 crore. Net revenue at the unit also retreated, coming in at Tk1,259 crore against Tk1,677.13 crore a year earlier. Those figures describe the Bangladeshi company's own top and bottom lines for the quarter — not the group's consolidated results.
On the shareholder register, Capital Group has nudged its voting stake in the London-listed tobacco giant lower. A regulatory notification filed on Wednesday put The Capital Group Companies' holding at 17.975584%, down from 18.023677% in the prior disclosure. The position spans roughly 387 million voting rights, held in accounts managed by affiliates of the asset manager. BAT shares shed 2.5% on Friday.
Organigram Bet Tied to Aurora Deal
Elsewhere, Organigram Global said on 3 November that BAT, through subsidiary BT DE Investments Inc., had agreed a £100 million investment linked to Organigram's proposed takeover of Aurora Cannabis. Under the arrangement, BAT is to subscribe for 141 million Organigram shares at C$1.33 apiece. Completion is expected in January 2027, subject to the necessary approvals.
Should investors sell immediately? Or is it worth buying British American Tobacco?
The transaction follows BAT's earlier agreement to commit C$187.5 million to Organigram, with media reports indicating the money would flow through a private placement. Both commitments sit within the same proposed Aurora combination.
Buyback Correction and Insider Purchases
BAT also issued a correction on 3 November to a prior notice on its own share purchases. Per the revised figures, the company bought about 597,000 ordinary shares under its buyback programme between 26 and 30 October, with the intention of cancelling the repurchased stock.
Separately, seven executives picked up three ordinary shares each under the company's Partnership Share Scheme, among them CEO Tadeu Marroco and COO Johan Vandermeulen. The purchases were made at £45.325 per share.
Goldman Lifts Rating and Target
Sentiment on the equity got a lift from Goldman Sachs, which — according to media reports on 2 November — upgraded BAT from "Neutral" to "Buy" and raised its twelve-month price target to 5,600 pence from 5,200 pence. The broker thus moved both its recommendation and its target for the stock.
Ad
British American Tobacco Stock: New Analysis - 9 November
Fresh British American Tobacco information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
